Envision Healthcare Holdings Inc (NYSE:EVHC) (TREND ANALYSIS) downgraded to Buy from Conviction Buy at Goldman. Goldman removed Envision Healthcare from the Conviction Buy List and maintained its Buy rating. The firm said valuation reflects investor expectations for the American Care Act. Goldman’s price target on shares is $43. :theflyonthewall.com
Stock Performance: Click here for a free comprehensive Trend Analysis Report
Envision Healthcare Holdings Inc (NYSE:EVHC) stock is currently trading 7.5% below its 52-week-high, 22.21% above its 52-week-low. The 1-year stock price history is in the range of $30.48 – $40.27. Envision Healthcare Holdings Inc (EVHC) has a price to earnings ratio of 53.21 versus Healthcare sector average P/E of 34.12. EVHC stock price has outperformed the S&P 500 by 4.3%. The Healthcare Services company is currently valued at $6.91 billion and its share price closed the last trading session at $37.25. The stock has a 50-day moving average of $37.57 and a 200-day moving average of $36.53.
Envision Healthcare Holdings Inc (EVHC) current short interest stands at 3.44 million shares. It has decreased by 1% from the same period of last month. Around 2% of the company’s shares, which are float, are short sold. With a 10-days average volume of 2.84 million shares, the number of days required to cover the short positions stand at 1.3 days.
EVHC reported last quarter earnings on April 30. The Healthcare Services company announced earnings per share of $0.26 against a consensus Street estimate of $0.26, matching the average estimate. This corresponds to an increase of $0.09 compared to the same quarter of the previous fiscal year.
Is this a Buying Opportunity? Click here for a free Trend Analysis Report
There are currently sixteen analysts that cover Envision Healthcare Holdings Inc stock. Of those sixteen, fourteen have a Buy rating, two have a Hold rating. On a consensus basis this yields to a Buy rating. The consensus target price stands at $43.5.
A recent analyst activity consisted of Jefferies reiterating their Buy stance on March 18. Jefferies increased their price target on EVHC from $40 to $47. This corresponds to a 26.17% upside from the last closing price. On the date of report, the stock closed at $37.77.
Barclays reiterated their Overweight stance on February 27. , and increased their price target on EVHC stock from $40 to $43. This corresponds to a 15.44% upside from the last closing price. On the date of report, the stock closed at $36.62.
Envision Healthcare Holdings, Inc. is a medical holding company. The Company, through its subsidiaries, provide medical services and solutions, including emergency, anesthesiology, hospitalist/inpatient care, radiology, tele-radiology and surgery. Envision also provides medical transportation services.